There is a consensus that CRC development is related to LPS-induced systemic inflammation, and these events alter the signal transduction of TLR4, NF-κB, and transforming growth factor beta 1 (TGF-β1) pathways [17,37]. The gene discussed is TGFB1; the disease is colorectal carcinoma.